Furthermore, we observed a strong positive correlation between CTBP2 expression in gliomas and the levels of all the SREBP genes tested (GlioVis platform, dataset CGGA [Zhao et al, 2017 and Fig S4]), which is in line with a possible role of CTBP2 as a co-activator of SREBP genes. This evidence concerns the gene CTBP2 and central nervous system cancer.